The Biden administration’s efforts to overhaul marketing practices within Medicare managed care could face significant delays due to ongoing legal battles. A recently introduced rule by the Department of Health and Human Services (HHS) aims to curb compensation for field marketing organizations (FMOs) that assist independent insurance agents and brokers. This has sparked a series of legal challenges, with plaintiffs arguing that the Centers for Medicare & Medicaid Services (CMS) overstepped its authority in finalizing the rule this past April.
According to industry insiders, the rule, if implemented, would dramatically reduce the fees agents, brokers, and FMOs receive. Proponents of the rule argue that these financial incentives have often led to potential enrollees being steered towards plans that may not best suit their needs. However, critics maintain that the CMS exceeded its statutory boundaries by enacting these restrictions.
In response to the lawsuits, a federal judge has temporarily halted the rule’s enforcement until the courts resolve the disputes. This delay underscores the complex interplay between regulatory goals and legal authority, and it places the administration’s objective of reducing biased plan recommendations in jeopardy.
The complete article detailing these developments can be read on Bloomberg Law’s website here.